Literature DB >> 8852378

Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP-43) and decreased proliferation and production of the growth factor S-100.

C Clarke1, K Clarke, J Muneyyirci, E Azmitia, P M Whitaker-Azmitia.   

Abstract

Exposure to cocaine during fetal development has been demonstrated to produce a variety of brain and behavioral changes. Cocaine is a potent releaser of a variety of neurotransmitters, such as serotonin, which act as developmental signals. Since serotonin plays an important role in astroglial maturation, migration, and growth factor production (e.g. S-100 beta), we proposed that these properties of astroglial cells will be altered in a brain prenatally exposed to cocaine. To observe cocaine's effects on astroglial development, we performed immunocytochemical analyses of a variety of developmental protein makers including BrdU, Gap-43, vimentin, and S100 beta. Our results demonstrate that prenatal cocaine administration produces decreased cell proliferation as measured by BrdU staining, retarded neurite outgrowth as ascertained by increased Gap-43 immunoreactivity, increased density of vimentin-positive radial glial cells, and diminished tissue S100 beta immunoreactivity. Overall, these results suggest that cocaine delays astroglial development. This delay would have profound effects on neuronal development and outgrowth and, thus, development of the entire brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852378     DOI: 10.1016/0165-3806(95)00192-1

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

1.  Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies.

Authors:  Ponnada A Narayana; Juan J Herrera; Kurt H Bockhorst; Emilio Esparza-Coss; Ying Xia; Joel L Steinberg; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2014-01-23       Impact factor: 3.222

2.  Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspring.

Authors:  Josephine M Johns; Deborah A Lubin; Jeffrey A Lieberman; Jean M Lauder
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

3.  Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.

Authors:  Benjamin S McKenna; Gregory G Brown; Sarah Archibald; Miriam Scadeng; Robert Bussell; James P Kesby; Athina Markou; Virawudh Soontornniyomkij; Cristian Achim; Svetlana Semenova
Journal:  Psychiatry Res Neuroimaging       Date:  2016-02-24       Impact factor: 2.376

4.  Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes.

Authors:  Tania Vitalis; Mark S Ansorge; Alexandre G Dayer
Journal:  Front Cell Neurosci       Date:  2013-06-19       Impact factor: 5.505

5.  Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

Authors:  Sarah K Williams; Jean M Lauder; Josephine M Johns
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 6.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Authors:  D C Dorman; S L Allen; J Z Byczkowski; L Claudio; J E Fisher; J W Fisher; G J Harry; A A Li; S L Makris; S Padilla; L G Sultatos; B E Mileson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

7.  Maternal-fetal unit interactions and eutherian neocortical development and evolution.

Authors:  Juan F Montiel; Heidy Kaune; Manuel Maliqueo
Journal:  Front Neuroanat       Date:  2013-07-19       Impact factor: 3.856

Review 8.  Risks of using SSRI / SNRI antidepressants during pregnancy and lactation.

Authors:  Michal Dubovicky; Kristína Belovicova; Kristína Csatlosova; Eszter Bogi
Journal:  Interdiscip Toxicol       Date:  2017-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.